Lenalidomide medication for the ST. Cloud VA health care system
Ended Awarded Last action
- Contract number
- 36C26326F0015
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,150,000
Award facts
- Contract value 100% obligated
- $1,150,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- St Cloud, MN 56303, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a delivery order to Exelan Pharmaceuticals Inc. on December 1, 2025, for the supply of Lenalidomide medication to support the St. Cloud VA Health Care System in Minnesota. This firm fixed-price delivery order carries a ceiling value of $1.15 million and is scheduled for completion by September 30, 2026. The contract was awarded without a set-aside designation, allowing Exelan to compete openly in an unrestricted procurement. This delivery order falls under the GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), leveraging the established federal supply schedule framework for pharmaceutical procurement.
Exelan Pharmaceuticals Inc., a pharmaceutical company headquartered in Boca Raton, Florida, specializes in manufacturing, distributing, and repackaging generic and branded pharmaceutical products for federal healthcare systems. The company maintains an established track record supplying medications to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through multiple federal contract vehicles and holds numerous Indefinite Delivery Contracts with ceiling values ranging from millions to tens of millions of dollars. Lenalidomide, a prescription medication used to treat certain blood cancers and multiple myeloma, will be repackaged and delivered in patient-ready formats to support the clinical needs of VA patients in the St. Cloud facility.
Quick answers
Who was awarded contract 36C26326F0015?
36C26326F0015 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on December 1, 2025.
How much is contract 36C26326F0015 worth?
The government has obligated $1,150,000 on 36C26326F0015.
Is contract 36C26326F0015 an order under another contract?
Yes. 36C26326F0015 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26326F0015 competed?
The extent of competition for 36C26326F0015 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award